Testing effectiveness (Phase 2)Study completedNCT04462198
What this trial is testing
Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss
Who this might be right for
Sensorineural Hearing Loss
Contineum Therapeutics 28